Hypofractionated Versus Standard Fractionated Proton-beam Therapy for Low-risk Prostate Cancer Interim Results of a Randomized Trial PCG GU 002

被引:23
作者
Vargas, Carlos E. [1 ]
Hartsell, William F. [2 ]
Dunn, Megan [3 ]
Keole, Sameer R. [1 ]
Doh, Lucius [4 ]
Eisenbeisz, Elaine [5 ]
Larson, Gary L. [4 ]
机构
[1] Mayo Clin Hosp, Dept Radiat Oncol, 5777 E Mayo Blvd, Phoenix, AZ 85054 USA
[2] CDH Proton Ctr, Warrenville, IL USA
[3] Proton Collaborat Grp, Warrenville, IL USA
[4] Radiat Med Associates PC, Radiat Oncol, Oklahoma City, OK USA
[5] Omega Stat, Murrieta, CA USA
来源
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 2018年 / 41卷 / 02期
关键词
adverse events; EPIC; outcomes; stereotactic body radiation therapy; toxicity; QUALITY-OF-LIFE; INTRAFRACTION MOTION; RADIATION-THERAPY; RANDOMIZED-TRIAL; RADIOTHERAPY; INDEX;
D O I
10.1097/COC.0000000000000241
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To identify differences in terms of quality of life, the American Urological Association Symptom Index (AUA), or adverse events (AEs) among patients with prostate cancer treated with either standard fractionation or hypofractionation proton-beam therapy. Materials and Methods: Patients were prospectively randomized to receive 38 Gy relative biological effectiveness (RBE) in 5 treatments (n = 49) or 79.2 Gy RBE in 44 treatments (n = 33). All patients had low-risk prostate cancer and were treated with proton therapy using fiducial markers and daily image guidance. Results: Median follow-up for both groups was 18 months; 33 patients had follow-up of 2 years or longer. Baseline median (range) AUA was 4.7 (0 to 13) for the 38 Gy RBE arm and 4.8 (0 to 17) for the 79.2 Gy RBE arm. We observed no difference between the groups regarding the Expanded Prostate Index Composite urinary, bowel, or sexual function scores at 3, 6, 12, 18, or 24 months after treatment. The only significant difference was the AUA score at 12 months (8 for the 38 Gy RBE arm vs. 5 for the 79.2 Gy RBE arm; P = 0.04); AUA scores otherwise were similar between groups. No grade 3 or higher AEs occurred in either arm. Conclusions: Patients treated with proton therapy in this randomized trial tolerated treatment well, with excellent quality-of-life scores, persistent low AUA, and no grade 3 or higher AEs on either arm. We showed no apparent clinical difference in outcomes with hypofractionated proton-beam therapy compared with standard fractionation on the basis of this interim analysis.
引用
收藏
页码:115 / 120
页数:6
相关论文
共 30 条
[1]   CyberKnife Stereotactic Radiotherapy as Monotherapy for Low- to Intermediate-Stage Prostate Cancer: Early Experience, Feasibility, and Tolerance [J].
Aluwini, Shafak ;
van Rooij, Peter ;
Hoogeman, Misha ;
Bangma, Chris ;
Kirkels, Wim J. ;
Incrocci, Luca ;
Kolkman-Deurloo, Inger-Karine .
JOURNAL OF ENDOUROLOGY, 2010, 24 (05) :865-869
[2]   THE AMERICAN-UROLOGICAL-ASSOCIATION SYMPTOM INDEX FOR BENIGN PROSTATIC HYPERPLASIA [J].
BARRY, MJ ;
FOWLER, FJ ;
OLEARY, MP ;
BRUSKEWITZ, RC ;
HOLTGREWE, HL ;
MEBUST, WK ;
COCKETT, ATK ;
BLAIVAS, JG ;
WEIN, AJ .
JOURNAL OF UROLOGY, 1992, 148 (05) :1549-1557
[3]   Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer [J].
Bhattasali, Onita ;
Chen, Leonard N. ;
Woo, Jennifer ;
Park, Jee-Won ;
Kim, Joy S. ;
Moures, Rudy ;
Yung, Thomas ;
Lei, Siyuan ;
Collins, Brian T. ;
Kowalczyk, Keith ;
Suy, Simeng ;
Dritschilo, Anatoly ;
Lynch, John H. ;
Collins, Sean P. .
RADIATION ONCOLOGY, 2014, 9
[4]   REAL-TIME STUDY OF PROSTATE INTRAFRACTION MOTION DURING EXTERNAL BEAM RADIOTHERAPY WITH DAILY ENDORECTAL BALLOON [J].
Both, Stefan ;
Wang, Ken Kang-Hsin ;
Plastaras, John P. ;
Deville, Curtiland ;
Bar Ad, Voika ;
Tochner, Zelig ;
Vapiwala, Neha .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (05) :1302-1309
[5]   Fractionation and late rectal toxicity [J].
Brenner, DJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (04) :1013-1015
[6]  
Brenner DJ, 2002, INT J RADIAT ONCOL, V52, P6
[7]   The radiobiology of prostate cancer including new aspects of fractionatedradiotherapy [J].
Fowler, JF .
ACTA ONCOLOGICA, 2005, 44 (03) :265-276
[8]   Predictors for chronic urinary toxicity after the treatment of prostate cancer with adaptive three-dimensional conformal radiotherapy: Dose-volume analysis of a phase II dose-escalation study [J].
Harsolia, Asif ;
Vargas, Carlos ;
Yan, Di ;
Brabbins, Donald ;
Lockman, David ;
Liang, Jian ;
Gustafson, Gary ;
Vicini, Frank ;
Martinez, Alvaro ;
Kestin, Larry L. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (04) :1100-1109
[9]   Hypofractionated radiotherapy for prostate cancer [J].
Hegemann, Nina-Sophie ;
Guckenberger, Matthias ;
Belka, Claus ;
Ganswindt, Ute ;
Manapov, Farkhad ;
Li, Minglun .
RADIATION ONCOLOGY, 2014, 9
[10]   Long-Term(10-Year) Gastrointestinal and Genitourinary Toxicity after Treatment with External Beam Radiotherapy, Radical Prostatectomy, or Brachytherapy for Prostate Cancer [J].
Hunter, Grant K. ;
Reddy, Chandana A. ;
Klein, Eric A. ;
Kupelian, Patrick ;
Angermeier, Kenneth ;
Ulchaker, James ;
Chehade, Nabil ;
Altman, Andrew ;
Ciezki, Jay P. .
PROSTATE CANCER, 2012, 2012